I agree that this site is using cookies. You can find further informations here.
X
Cortes, Javier
5764  results:
Search for persons X
?
1

Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PI..:

Llombart-Cussac, Antonio ; Pérez-Garcia, José Manuel ; Ruiz Borrego, Manuel...
eClinicalMedicine.  71 (2024)  - p. 102520 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Management of early-stage HER2-positive breast cancer and a..:

Martínez-Sáez, Olga ; Cortés, Javier ; Ciruelos, Eva...
Clinical and Translational Oncology.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

6th and 7th International consensus guidelines for the mana..:

Cardoso, Fatima ; Paluch-Shimon, Shani ; Schumacher-Wulf, Eva...
The Breast.  76 (2024)  - p. 103756 , 2024
Link: https://doi.org/10.1016/..
 
?
4

The evolving value assessment of cancer therapies: Results ..:

Lee, Myrto ; Larose, Hugo ; Gräbeldinger, Martin...
Health Policy OPEN.  6 (2024)  - p. 100116 , 2024
Link: https://doi.org/10.1016/..
 
?
5

CDH1 methylation analysis in invasive lobular breast carcin..:

González-Martínez, Silvia ; Kajabova, Viera Horvathova ; Pérez-Mies, Belén...
Virchows Archiv.  , 2024
Link: https://doi.org/10.1007/..
 
?
6

Trastuzumab deruxtecan versus trastuzumab emtansine in Asia..:

Iwata, Hiroji ; Xu, Binghe ; Kim, Sung‐Bae...
Cancer Science.  , 2024
Link: https://doi.org/10.1111/..
 
?
7

Exploring the Combined Action of Adding Pertuzumab to Brand..:

Franco-Mateos, Emma ; Souza-Egipsy, Virginia ; García-Estévez, Laura...
International Journal of Molecular Sciences.  25 (2024)  7 - p. 3940 , 2024
Link: https://doi.org/10.3390/..
 
?
8

Impact of coadministration of proton-pump inhibitors and pa..:

Di Cosimo, Serena ; Pérez-García, José Manuel ; Bellet, Meritxell...
The Breast.  76 (2024)  - p. 103761 , 2024
Link: https://doi.org/10.1016/..
 
?
9

3-year invasive disease-free survival with chemotherapy de-..:

Pérez-García, José Manuel ; Cortés, Javier ; Ruiz-Borrego, Manuel...
The Lancet.  403 (2024)  10437 - p. 1649-1659 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Author Correction: Safety analyses from the phase 3 ASCENT ..:

Rugo, Hope S. ; Tolaney, Sara M. ; Loirat, Delphine...
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
11

Disease-free survival as a surrogate for overall survival i..:

Untch, Michael ; Pérol, David ; Mayer, Erica L....
European Journal of Cancer.  202 (2024)  - p. 113977 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Essential requirements for reporting radiation therapy in b..:

Kaidar-Person, Orit ; Meattini, Icro ; Boersma, Liesbeth J....
Radiotherapy and Oncology.  195 (2024)  - p. 110060 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Health-related quality of life with sacituzumab govitecan i..:

Rugo, Hope S ; Schmid, Peter ; Tolaney, Sara M...
The Oncologist.  , 2024
Link: https://doi.org/10.1093/..
 
?
14

Validation of immunohistochemical overexpression of p16 in ..:

Forteza, Ana ; Vanrell, Cristina ; Matheu, Gabriel.
Revista Española de Patología.  57 (2024)  3 - p. 169-175 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Hidden secrets of the cancer genome: unlocking the impact o..:

Iñiguez-Muñoz, Sandra ; Llinàs-Arias, Pere ; Ensenyat-Mendez, Miquel...
Cellular and Molecular Life Sciences.  81 (2024)  1 - p. , 2024
Link: https://doi.org/10.1007/..
 
1-15